Urawa, Japan

Kensei Yoshikawa


 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Kitamoto, JP (1980 - 1984)
  • Saitama, JP (1985)
  • Urawa, JP (1989 - 1994)
  • Tokyo, JP (1995 - 1996)

Company Filing History:


Years Active: 1980-1996

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Inventor Kensei Yoshikawa: A Trailblazer in Pharmaceutical Innovations

Introduction

Kensei Yoshikawa is a prominent inventor based in Urawa, Japan, recognized for his significant contributions to the pharmaceutical field. With an impressive portfolio of 10 patents, Yoshikawa has made strides in the development of innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents are the formulations involving 5-aminoacetylaminosulfonanilide compounds and 5-amino-2-phenoxysulfonanilide compounds. These inventions showcase his expertise and creativity in creating new pharmaceutical solutions.

Career Highlights

Kensei Yoshikawa has worked with notable organizations, including Taisho Pharmaceutical Co., Ltd. and The Institute of Materia Medica of the Chinese Academy of Medical Sciences. His experience in these esteemed establishments has provided him the opportunity to further his research and innovation in medicine.

Collaborations

Throughout his career, Yoshikawa has collaborated with distinguished colleagues, including Katsuo Hatayama and Tatsuhiko Sano. These partnerships have played a crucial role in advancing their collective research objectives and in fine-tuning pharmaceuticals that can benefit society.

Conclusion

Kensei Yoshikawa's contributions to pharmaceutical innovations, with significant patents under his name, highlight his status as a leading inventor in his field. His work continues to pave the way for future developments and improvements in medical science, reflecting the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…